PMS60 QUALITATIVE STEPS FOR THE DEVELOPMENT OF A QUESTIONNAIRE ASSESSING THE BURDEN OF FIBROMYALGIA ON PATIENTS' DAILY LIVES  by Arnould, B et al.
maries [PCS and MCS], the physical functioning domain [PF]).
To demonstrate responsiveness, mean changes in WPS-RA at
wk24 were compared between ACR20 responders and non-
responders. The Standardized Response of the Mean (SRM) was
used to quantify responsiveness. Comparisons were conducted
using a non-parametric bootstrap t-method. RESULTS: Subjects
with lower physical function/HRQoL scores had statistically
greater RA-associated productivity losses compared to subjects
with higher scores (25/32 evaluations statistically signiﬁcant).
HAQ-DI and SF-36 PF thresholds lead to statistically signiﬁcant
differences between groups in 7/8 WPS-RA questions. The PCS
showed differences in 6/8 questions; the MCS in 5/8. The smallest
differences related to absenteeism and days with outside help. At
wk24, ACR20 responders reported large gains in productivity,
whereas the ACR20 non-responders reported mainly worsening
(difference p-value  0.05). The effect size for changes in pro-
ductivity in responders was moderate to large for 6/8 items
(0.49–1.10). The effect size was small for absenteeism and days
with outside help (SRM = 0.4 and 0.24 respectively). In compari-
son, in non-responders, the magnitude of change was negligible
(SRM < 0.1) or small (SRM < 0.3). CONCLUSIONS: The
WPS-RA is valid and responsive as measure of work and house-
hold productivity in subjects with active RA.
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OBJECTIVES: To establish pertinent levels of FMQ (Fibromyal-
gia Moldofsky Questionnaire) score to guide a subject’s further
treatment, METHODS: The FMQ questionnaire, was adminis-
trated to a representative community sample of 1500 subjects in
UK along with two validated questionnaires (LFESSQ London
Fibromyalgia Epidemiology Study Screening Questionnaire and
CES-D Center for Epidemiologic Studies Depression Scale) and a
questionnaire assessing a decline in the restorative effects of sleep
(SQA Sleep Quality Assessment). A descriptive analysis of the
score was carried out using socio-demographic data (gender, age,
type of town and socio-professional class) and the complaints
reported by the subjects interviewed, RESULTS: The FMQ score
was higher among women and those over 50 (5.0; 5.3). Women
aged over 50 had an even higher FMQ score (5.5), which agreed
with existing epidemiological data on ﬁbromyalgia. There was
no relationship between the FMQ score and geographic location,
income, profession and sick leave prescribed by a doctor (regard-
less of length). The FMQ score was 3.0 in subjects who did not
state any pain and 4.1 in those who did not respond positively on
the LFESSQ. It increased to 8.7 among those who screened
positive on the LFESSQ. The FMQ score varied between 9.7 and
10.4 in subjects who responded positively on the LFESSQ and
who also experienced depressive symptoms, fatigue or a decline
in the restorative effects of sleep. The FMQ score was 10.7 for
subjects who screened positive on the LFESSQ and who also
experienced fatigue and depressive symptoms, and increased to
11.3 when the four symptoms were experienced at once, CON-
CLUSIONS: A FMQ score of less than 3 excludes a presumptive
diagnosis of ﬁbromyalgia syndrome and an FMQ score of above
8 should lead to specialist investigations.
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OBJECTIVES: To validate the SQA (Sleep Quality Assessment)
questionnaire which will help to identify subjects who with
an unrestorative sleep, METHODS: The SQA questionnaire,
was administered to a representative sample of 1500 subjects
from the general UK population along with three questionnaires
(FMQ: Fibromyalgia Moldofsky Questionnaire, LFESSQ
London Fibromyalgia Epidemiology Study Screening Question-
naire, and CES-D Center for Epidemiologic Studies Depression
Scale). The maximum score of 30 showed a large decline in the
restorative effect of sleep. Internal consistency, structural and
clinical validity were tested, RESULTS: Internal consistency was
highly satisfactory (aCronbach > 0.8). The items making up each
dimension were highly relevant to the dimension that they
covered (R > 0.4) and no item presented a signiﬁcant correlation
(>0.8) with another item. Subjects responding positively on the
LFESSQ had an SQA score that was signiﬁcantly higher than
subjects who responded negatively (14.6 vs 8.7). Similar differ-
ences were observed between subjects with and without probable
depressive symptoms (15.4 vs 8.4) and a strong presumption of
ﬁbromyalgia syndrome (16.9 vs 8.0). The SQA score was 7.0 in
subjects who did not report any pain and 7.1 in those who did
not respond positively on the LFESSQ. It increased to 14.7
among those who screened positive on the LFESSQ. The CES-D
score increased signiﬁcantly with the SQA score. The SQA score
was 16.7 [13.9–17.4] among subjects who screened positive on
the LFESSQ and who either experienced fatigue or depressive
symptoms or both, CONCLUSIONS: The restorative effect of
sleep is reduced when the SQA score is greater or equal to 14 and
good when the SQA score is less than 7. An SQA score of
between 7 and 14 necessitates further examinations, which may
include investigating physiological function during sleep.
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OBJECTIVES: To explore functional impact, limitation of daily
activities, burden and handicap related to FM in order to deﬁne
the burden on patients’ daily lives. To gather and organise this
material to develop a new Patient-Reported Outcomes (PRO)
questionnaire simultaneously in four European languages assess-
ing FM burden on patients’ daily lives. METHODS: PRO
questionnaire development follows a rigorous protocol and
methodology to ensure its reliability. An international committee
of three ﬁbromyalgia experts was set up and included in the
whole process. A literature review was conducted using burden-
and FM-related keywords. Concepts identiﬁed were organised
into a model. Exploratory interviews were performed with a
total of 15 patients in France, Germany and Spain. They were
recorded, transcribed word-for-word and systematically analysed
using a speciﬁcally developed coding grid. Concepts were orga-
nised into a separate model. Conﬁrmatory interviews were
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conducted with 9 FM-association counsellors in 3 countries,
analysed using the same method and used to enrich the model.
Further information was captured with the analysis of 90 letters
written by patients to FM-associations. RESULTS: A total of 303
abstracts were retrieved and reviewed. Sixty-seven publications
were included and the concepts identiﬁed were grouped into the
following domains: Burden, Symptoms and Inﬂuencing Factors.
The exploratory interviews suggested that burden can be divided
into: Autonomy, Coping, Pain, Tiredness, Activities of Daily
Living, Physical Impact, Social Impact, Psychological Impact,
Cognitive Impact, Work, Sleep, Relationship to Medicine and
Disease. The letters and counsellor interviews conﬁrmed the con-
ceptual content. CONCLUSIONS: The resulting model illus-
trates how “burden” is understood by FM patients, and that all
areas of daily life are impacted by the disease. The conceptual
content will be used for the generation of items for the question-
naire. The development of a questionnaire assessing functional
impact and burden will allow the consequences of FM on
patients to be more widely recognised.
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OBJECTIVES: Background: Minor injury is a leading cause of
PED visits and a major health care burden. However, little is
known about outcomes after treatment and release; care often
lacks an evidence base. OBJECTIVES: 1) Gather initial data on
the clinical/functional outcomes after PED care, and 2) Test
both patient and proxy forms of an acute HRQOL tool in the
PED and in telephone follow-up. METHODS: Prospective con-
venience sample of pediatric patients treated for injury and dis-
charged to home. Demographic and injury data collected at the
visit; outcomes by telephone at 7–10 days. The acute Pediatric
Quality of Life Inventory 4.0 (PedsQL) was administered at
both visit and follow-up. RESULTS: Thirty-ﬁve families com-
pleted follow-up. Mean patient age = 8 years, 69% male, 49%
soft tissue injury, 31% fracture, 17% sprains, 3% CHI. Types/
locations of study injuries were in frequencies similar to those
in our ED overall. Children had a median of 3 days of pain;
24% reported 37 after the visit. Days for the child’s return to
normal activity: median 3, 37% 37. Disruption of normal
family activities in 51%, for a median of 5 days, 39% 37. Chil-
dren with school, work, or other regularly scheduled activities:
55% missed 33 days, 20% missed 37. Parents missed work or
school: mean 1 day, 22% 33. The PedsQL was found to be easy
to use, had minimal missing items, and good indication con-
struct validity (total scores inversely correlating to days of pain,
abnormal activities, and family disruption). CONCLUSIONS:
We found signiﬁcant morbidity for patients and their families
after PED visits for minor injury. In this setting, the use of the
acute PedsQL patient/proxy forms was feasible with initial indi-
cations of good construct validity. Further description and the
development/testing of a tool to quantify short-term outcomes
are prerequisites to testing effectiveness in ED minor injury
care.
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BACKGROUND: Anti-TNF therapies are efﬁcacious in clinical
trials for the treatment of RA.However, their long-term efﬁcacy in
daily practice in relation to the speciﬁc diagnosis or the use of
concomitant DMARD therapy remains to be conﬁrmed. OBJEC-
TIVES: To estimate the proportion of patients with RA, treated
with at least one anti-TNF therapy (inﬂiximab [IFX], etanercept
[ETN], or adalimumab [ADA]), who were still on the same
biologic agent after 3 yrs (36 mths) of follow-up. To estimate the
discontinuation rate of patients with RA, treated with the second
anti-TNF therapy, after discontinuing the ﬁrst one. METHODS:
Patients attending participating centers who received their ﬁrst
anti-TNF treatment between July 1, 2002 and March 31, 2004,
and who gave their consent, were invited to participate to the
study. Pts were required to be18 yrs old, with a diagnosis of RA
(as deﬁned by the ACR criteria). A total of 711 patients were
enrolled in this retrospective cohort study involving a national
representative sample of 23 rheumatology centers in Italy, selected
according to both geography and treatment setting characteristics.
A patient chart review was conducted to collect data on treatment
duration, and a diary of therapies was completed. A Kaplan–
Meier curve was calculated for each biologic anti-TNF therapy;
the event was discontinuation of the drug due to inefﬁcacy or
toxicity. RESULTS: Pts’ baseline characteristics were: female
80.8%, mean age 53.3 yrs (range 18–84 yrs), mean duration of
disease 9.4 yrs. Of 703 pts who met the inclusion criteria, 248
(35.3%) were treated with IFX, 259 (36.8%) with ETN and 196
(27.9%) with ADA. After a follow-up of 36 months, the discon-
tinuation rate was 43.2% with IFX, 25.8% with ETN and 28.0%
with ADA. The discontinuation rate of IFX compared with ETN
and ADA was statistically higher (p = 0.0001 and p = 0.0002,
respectively). The difference between ADA and ETN was not
statistically signiﬁcant (p = 0.826). Patients who discontinued the
ﬁrst agent and started the second onewere 149: ETN112, INF 12,
ADA 25. After 24 months of follow up 78% patients on ETN,
46% on ADA and 25% on INF were still on the same agent. The
RR of stopping the second agent increased by 31% (IC 95%
0.96–1.83). CONCLUSIONS: Our results show a higher discon-
tinuation rate of anti-TNF therapies in daily practice in Italy
compared with clinical trials. IFX was associated with a signiﬁ-
cantly higher rate of drug discontinuation than other anti-TNFs.
Patients who stopped the ﬁrst agent and switched to the second
one had a discontinuation risk increase of of 31%. This results
should be taken into account when ﬁrst agent fails.
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OBJECTIVES: To determine surgical treatment outcomes in
patients with cartilage defects according to operative procedures
performed. METHODS: In this 5-year retrospective cross-
sectional study patients were contacted who had been diagnosed
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